(Q37205725)

18 August 2017

0 references

1 reference

title

A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery (English)

1 reference

18 August 2017

1 reference

David Benglis

1

1 reference

18 August 2017

Michael Y Wang

series ordinal

2

1 reference

18 August 2017

Allan D Levi

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

62

1 reference

18 August 2017

issue

5 Suppl 2

1 reference

18 August 2017

page(s)

ONS423-31; discussion ONS431

1 reference

Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion: an evidence-based modeling approach

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Bone morphogenetic proteins for spinal fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Bone morphogenetic proteins and their receptors: potential functions in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Posterolateral lumbar spine fusion with INFUSE bone graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Comparing ectopic bone growth induced by rhBMP-2 on an absorbable collagen sponge in rat and rabbit models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Measurement of total and local bone morphogenetic protein concentration in bone tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Bone morphogenetic protein signalling and vertebrate nervous system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Bone morphogenetic proteins in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Human BMP sequences can confer normal dorsal-ventral patterning in the Drosophila embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Tumors of the osseous spine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Bone: formation by autoinduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Bone morphogenetic proteins and spinal fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

Osteogenic protein-1 : a review of its utility in spinal applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000326030.24220.D8

10.1227/01.NEU.0000326030.24220.D8

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference